SCHEMBL30906375

SCHEMBL30906375

CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC

nearest known ligand 0.71

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GLP1R P43220 20/20 0.71
ECE1 P42892 1/20 0.71
MUS81 Q96NY9 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30607465 0.93 GLP1R (0.71) GLP1RECE1MUS81
SCHEMBL30874399 0.92 GLP1R (0.75) GLP1RECE1MUS81
SCHEMBL31000903 0.92 GLP1R (0.71) GLP1RECE1MUS81
SCHEMBL31378965 0.91 GLP1R (0.71) GLP1RECE1MUS81
SCHEMBL30658330 0.91 GLP1R (0.70) GLP1RECE1MUS81
SCHEMBL31000941 0.91 GLP1R (0.71) GLP1RECE1MUS81
SCHEMBL30431337 0.91 GLP1R (0.70) GLP1RECE1MUS81
SCHEMBL31182873 0.91 GLP1R (0.68) GLP1RECE1MUS81
SCHEMBL31073508 0.91 GLP1R (0.63) GLP1RECE1MUS81
SCHEMBL30883240 0.90 GLP1R (0.71) GLP1RECE1MUS81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4598964-A2 ANTI-IGE ANTIBODIES Abwiz Bio, Inc. (US) 2025-08-13 EP disclosed
US-20240182599-A1 ANTI-IGE ANTIBODIES ABWIZ BIO, INC. 2024-06-06 US disclosed
WO-2024076785-A2 ANTI-IGE ANTIBODIES ABWIZ BIO, INC. (US) 2024-04-11 WO disclosed